Net Cash Provided by (Used in) Financing Activities of CONMED Corp from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
CONMED Corp annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • CONMED Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $28,398,000, a 67% decline year-over-year.
  • CONMED Corp annual Net Cash Provided by (Used in) Financing Activities for 2025 was $135,820,000, a 10% increase from 2024.
  • CONMED Corp annual Net Cash Provided by (Used in) Financing Activities for 2024 was $151,000,000, a 37% decline from 2023.
  • CONMED Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $110,432,000, a 149% decline from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

CONMED Corp Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $135,820,000 +$15,180,000 +10% 01 Jan 2025 31 Dec 2025 10-K 17 Feb 2026 2025 FY
2024 $151,000,000 -$40,568,000 -37% 01 Jan 2024 31 Dec 2024 10-K 17 Feb 2026 2025 FY
2023 $110,432,000 -$335,432,000 -149% 01 Jan 2023 31 Dec 2023 10-K 17 Feb 2026 2025 FY
2022 $225,000,000 +$326,548,000 01 Jan 2022 31 Dec 2022 10-K 18 Feb 2025 2024 FY
2021 $101,548,000 -$49,489,000 -95% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $52,059,000 -$352,940,000 -117% 01 Jan 2020 31 Dec 2020 10-K 21 Feb 2023 2022 FY
2019 $300,881,000 +$373,146,000 01 Jan 2019 31 Dec 2019 10-K 22 Feb 2022 2021 FY
2018 $72,265,000 -$37,384,000 -107% 01 Jan 2018 31 Dec 2018 10-K 22 Feb 2021 2020 FY
2017 $34,881,000 -$217,424,000 -119% 01 Jan 2017 31 Dec 2017 10-K 24 Feb 2020 2019 FY
2016 $182,543,000 +$195,165,000 01 Jan 2016 31 Dec 2016 10-K 25 Feb 2019 2018 FY
2015 $12,622,000 +$13,768,000 +52% 01 Jan 2015 31 Dec 2015 10-K 26 Feb 2018 2017 FY
2014 $26,390,000 +$4,906,000 +16% 01 Jan 2014 31 Dec 2014 10-K 27 Feb 2017 2016 FY
2013 $31,296,000 -$42,649,000 -376% 01 Jan 2013 31 Dec 2013 10-K 23 Feb 2016 2015 FY
2012 $11,353,000 +$78,052,000 01 Jan 2012 31 Dec 2012 10-K 23 Feb 2015 2014 FY
2011 $66,699,000 -$51,093,000 -327% 01 Jan 2011 31 Dec 2011 10-K 24 Feb 2014 2013 FY
2010 $15,606,000 01 Jan 2010 31 Dec 2010 10-K 25 Feb 2013 2012 FY

CONMED Corp Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $28,398,000 -$11,384,000 -67% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q1 2024 $17,014,000 -$22,364,000 -418% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q1 2023 $5,350,000 -$2,139,000 -29% 01 Jan 2023 31 Mar 2023 10-Q 25 Apr 2024 2024 Q1
Q1 2022 $7,489,000 +$16,361,000 01 Jan 2022 31 Mar 2022 10-Q 27 Apr 2023 2023 Q1
Q1 2021 $8,872,000 -$11,611,000 -424% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $2,739,000 -$376,215,000 -99% 01 Jan 2020 31 Mar 2020 10-Q 29 Apr 2021 2021 Q1
Q1 2019 $378,954,000 +$412,250,000 01 Jan 2019 31 Mar 2019 10-Q 30 Apr 2020 2020 Q1
Q1 2018 $33,296,000 -$27,030,000 -431% 01 Jan 2018 31 Mar 2018 10-Q 26 Apr 2019 2019 Q1
Q1 2017 $6,266,000 -$228,706,000 -103% 01 Jan 2017 31 Mar 2017 10-Q 26 Apr 2018 2018 Q1
Q1 2016 $222,440,000 +$227,074,000 01 Jan 2016 31 Mar 2016 10-Q 27 Apr 2017 2017 Q1
Q1 2015 $4,634,000 +$6,573,000 +59% 01 Jan 2015 31 Mar 2015 10-Q 02 May 2016 2016 Q1
Q1 2014 $11,207,000 -$18,841,000 -247% 01 Jan 2014 31 Mar 2014 10-Q 24 Apr 2015 2015 Q1
Q1 2013 $7,634,000 -$48,182,000 -86% 01 Jan 2013 31 Mar 2013 10-Q 25 Apr 2014 2014 Q1
Q1 2012 $55,816,000 +$67,529,000 01 Jan 2012 31 Mar 2012 10-Q 29 Apr 2013 2013 Q1
Q1 2011 $11,713,000 01 Jan 2011 31 Mar 2011 10-Q 01 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.